Market revenue in 2022 | USD 79.2 million |
Market revenue in 2030 | USD 99.0 million |
Growth rate | 2.8% (CAGR from 2022 to 2030) |
Largest segment | Antibiotics |
Fastest growing segment | Antimicrobial |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Antimicrobial, Antibiotics |
Key market players worldwide | Boehringer Ingelheim, CEVA Inc, Elanco Animal Health Inc, Neogen Corp, Phibro Animal Health Corp Class A, Vetoquinol SA, Virbac SA, Zoetis Inc Class A |
Antibiotics was the largest segment with a revenue share of 57.95% in 2022. Horizon Databook has segmented the Latin America animal antimicrobial and antibiotics market based on antimicrobial, antibiotics covering the revenue growth of each sub-segment from 2018 to 2030.
Central & South America emerged as the major market for animal antimicrobial and antibiotic in 2022 it is anticipated to witness a strong demand owing to the growing animal antimicrobial and antibiotics, primarily in Brazil
Brazil is a significant producer and exporter of food, so it is important to consider the panorama of resistant bacteria related to farm animals. Poultry feed emerged as the largest feed additive segment in this market owing to the strong presence of Brazilian poultry in the global poultry industry. As per Foreign Agriculture Service consumption for poultry and products is 10.54 million tons in 2022.
Favorable feed cost is another major factor which is positively impacting the Brazilian animal antimicrobial and antibiotic market as antimicrobial and antibiotics are commonly used in poultry feed to prevent and treat infections in chickens, ducks, and others.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account